CAS: 122063-01-8 - H-ASP-SER-PHE-VAL-BETA-ALA-LEU-MET-NH2
Fórmula:C35H56N8O10S
InChI:InChI=1/C35H56N8O10S/c1-19(2)15-24(32(50)40-23(30(37)48)12-14-54-5)39-27(45)11-13-38-35(53)29(20(3)4)43-33(51)25(16-21-9-7-6-8-10-21)41-34(52)26(18-44)42-31(49)22(36)17-28(46)47/h6-10,19-20,22-26,29,44H,11-18,36H2,1-5H3,(H2,37,48)(H,38,53)(H,39,45)(H,40,50)(H,41,52)(H,42,49)(H,43,51)(H,46,47)/t22-,23-,24?,25?,26-,29-/m0/s1
- Sinónimos:
- [Bala8]-Neurokinin A(4-10)
- Asp-Ser-Phe-Val-Beta-Ala-Leu-Met-Nh2
- (Beta-Ala8)-Neurokinin A (4-10)
- Dsfv-Beta-Alm
- Dsfv-(Beta-A)-Lm-Nh2
- Neurokinin A (4-10) (B-Ala8) Synthetic > 97% Nk2 Tachykinin Recept
- neurokinin A (4-10), beta-Ala(8)-
- L-alpha-aspartyl-L-serylphenylalanyl-L-valyl-beta-alanylleucyl-L-methioninamide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
L-Methioninamide, L-α-aspartyl-L-seryl-L-phenylalanyl-L-valyl-β-alanyl-L-leucyl- REF: AN-AG0016P9CAS: 122063-01-8 | ≥98% | A consultar | Vie 03 May 24 | |
[bAla8]-Neurokinin A(4-10) REF: TM-TP1100CAS: 122063-01-8 | 98% | A consultar | Lun 06 May 24 | |
[bAla8]-Neurokinin A(4-10) REF: 3D-XEA06301CAS: 122063-01-8 | Min. 95% | A consultar | Vie 14 Jun 24 |
L-Methioninamide, L-α-aspartyl-L-seryl-L-phenylalanyl-L-valyl-β-alanyl-L-leucyl-
Ref: AN-AG0016P9
1mg | 163,00 € | |
5mg | 500,00 € | |
10mg | A consultar | |
25mg | A consultar |
[bAla8]-Neurokinin A(4-10)
Ref: TM-TP1100
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar |
[bAla8]-Neurokinin A(4-10)
Ref: 3D-XEA06301
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |